Publications by authors named "Tina Drimes"
Article Synopsis
- A 13-year-old boy with optic pathway/hypothalamic glioma developed slipped capital femoral epiphysis (SCFE) after being treated with the FGFR TKI inhibitor erdafitinib.
- Following treatment, he experienced knee pain, which led to the diagnosis of SCFE via X-ray.
- After stopping erdafitinib and having surgery for his hip, the boy's tumor size decreased significantly, emphasizing the importance of monitoring for skeletal side effects in pediatric patients on pan-FGFR TKIs.
